Facial Nerve Paralysis and Chronic Suppurative Otitis Media

Describe the fiber composition and four nuclei functions of the Facial Nerve (CN VII).

The Facial Nerve is a mixed nerve with about 10,000 total fibers: approximately 7,000 motor fibers (the majority) and 3,000 non-motor fibers.

Its four brainstem nuclei (located in the Lower Pons) are: Motor (controls facial expression muscles and stapedius), Superior Salivatory Nucleus (parasympathetic/secretomotor to lacrimal glands via the greater superficial petrosal nerve, and to nasal/submandibular/sublingual/palatal glands via chorda tympani), Tractus Solitarius (taste for the anterior two-thirds of the tongue via chorda tympani), and Somatic Sensation (minimal clinical impact).

Describe the full anatomical course of the Facial Nerve from the pons to its terminal branches, including its five segments.

The facial nerve begins at the facial motor nucleus in the pons, loops around the abducent nucleus, exits the lower pons, and crosses the cerebellopontine angle with CN VIII.
It enters the internal auditory canal (labyrinthine segment, the narrowest part of the fallopian canal), reaches the geniculate ganglion (giving off the greater superficial petrosal nerve at the first genu), passes horizontally above the promontory (tympanic/horizontal segment), turns downward at the second genu above the oval window (mastoid/vertical segment, giving off the nerve to stapedius and chorda tympani), then exits via the stylomastoid foramen through the parotid gland, dividing into five terminal branches: temporal, zygomatic, buccal, mandibular, and cervical.

List the intra-temporal and extra-temporal branches of the Facial Nerve.

Intra-temporal branches: Greater superficial petrosal nerve (parasympathetic secretory), Nerve to stapedius muscle, and Chorda Tympani (taste).
Extra-temporal branches: Post-auricular nerve, nerve to stylohyoid and posterior belly of digastric, Cranio-temporal division, and Cranio-cervical division.

Describe the three connective tissue layers of a nerve and Seddon's three-tier classification of nerve injury.

The three connective tissue layers are the Endoneurium (wraps individual axons/fibers), Perineurium (wraps a bundle of fibers/fascicle), and Epineurium (wraps the entire nerve trunk).

Seddon's classification includes:
Neuropraxia (temporary physiological block, no physical cut, fast recovery),
Axonotmesis (axon is cut but the sheath is intact), and
Neurotmesis (complete severance of the nerve and its coverings, with worse regeneration and possible traumatic neuroma formation).

Compare Seddon's classification to Sunderland's five-tier classification of nerve injury.

Seddon's Neuropraxia corresponds to Sunderland Grade I (physiological block only).
Seddon's Axonotmesis corresponds to Sunderland Grade II (axon disrupted) or III (axons and endoneurium disrupted).
Seddon's Neurotmesis corresponds to Sunderland Grade IV (axons, endoneurium, and perineurium disrupted) or V (complete transection including the epineurium).

Describe the five clinical inspection tests used to diagnose facial nerve paralysis.

1) At-Rest Observation: checking symmetry, nasolabial fold, and corner of mouth for drooping;
2) Forehead Wrinkling: asking the patient to raise eyebrows to check for symmetrical wrinkles versus a smooth (paralyzed) forehead;
3) Eye Closure: assessing for Bell's Phenomenon (eyeball rolls upward, exposing sclera, since the eyelid cannot descend);
4) Smiling/Showing Teeth: the mouth deviates toward the healthy/strong side;
5) Puffing Cheeks: air leaks through the paralyzed side since the patient cannot maintain pressure. Wallerian Degeneration (distal nerve fiber death) takes 3-5 days to manifest after injury.

Differentiate Upper Motor Neuron Lesion (UMNL) from Lower Motor Neuron Lesion (LMNL) facial palsy, including emotional sparing.

UMNL (e.g., stroke, tumor) causes paralysis of only the lower face because the forehead still receives signals from the healthy brain side; there is "emotional sparing," meaning the patient cannot smile voluntarily on command but can smile naturally at a joke.

LMNL causes paralysis of the entire half of the face (forehead plus mouth), with both voluntary and emotional movements lost; it may be a Nuclear lesion (associated with crossed hemiplegia, crossed hemianesthesia, and other cranial nerve palsies especially CN VI, with normal lacrimation/salivation/taste) or Infranuclear.

The House-Brackmann Scale grades severity from Grade 1 (normal) to Grade 6 (total paralysis).

Compare the type of paralysis, distribution, and innervation patterns between UMNL and LMNL facial palsy.

UMNL causes Spastic paralysis limited to the lower face with intact emotional expressions and crossed hemiplegia as another sign;

LMNL causes Flaccid paralysis of the whole face with absent emotional expressions and no crossed hemiplegia.

This occurs because the upper face receives dual/bilateral innervation (from both cerebral hemispheres), while the lower face receives only contralateral innervation (from the opposite hemisphere); UMNL indicates a supranuclear lesion, while LMNL indicates a nuclear or infranuclear lesion.

Describe the four topographic diagnosis tests used to localize a facial nerve lesion.

Schirmer's Tear Test compares tear production between the two eyes; a difference greater than 30% indicates injury to the ipsilateral greater superficial petrosal nerve.

The Stapedius Reflex Test detects injury to the nerve to stapedius. Taste Evaluation detects chorda tympani injury. The Submandibular Salivary Flow (Lemon) Test compares saliva production between glands; a difference greater than 30% indicates ipsilateral chorda tympani injury.

Clinically: dry eyes suggest a lesion at/before the first genu, lost taste/stapedial reflex with normal tears suggests a middle ear lesion, and isolated motor loss suggests a lesion outside the bone (stylomastoid foramen).

Describe the three electrodiagnostic tests for facial nerve injury: Maximum Stimulation Test, ENOG, and EMG.

The Maximum Nerve Excitability Test (Hilgers test) compares the involved side's response to faradic stimulation against the normal side; even a completely cut nerve may conduct distally for 24-72 hours before Wallerian degeneration eliminates the response, so testing ideally starts on day 3.

Electroneurography (ENOG) is a quantitative test recording evoked compound action potentials, comparing amplitude to the healthy side; degeneration over 90% indicates poor recovery prognosis.

Electromyography (EMG) explores the paralyzed side with a needle during voluntary movement attempts: voluntary CAPs in the first 10 days indicate less than total transection, fibrillation after 10-14 days indicates denervation, and results become prognostic after 10 weeks.

List the six etiological categories of facial nerve lesions, separated into supranuclear/nuclear and infranuclear causes.

Supra-nuclear or nuclear causes: hemorrhage, vascular events, encephalitis, tumors, cerebral palsy.

Infra-nuclear causes include:
Congenital (poor facial muscular development), Inflammatory (malignant external otitis, AOM, chronic OM, cholesteatoma, Herpes zoster oticus/Ramsay Hunt syndrome, Lyme disease), Traumatic (skull base fracture, forceps delivery), Toxic (diphtheria, tetanus), Metabolic (diabetes), Neoplastic (facial nerve neuroma, secondary tumors of middle ear/parotid/CPA), Iatrogenic (mastoid, parotid, CPA surgery), and Idiopathic (Bell's palsy).

List the complications of facial nerve paralysis caused directly by the paralysis itself versus those caused by abnormal nerve degeneration.

Direct complications from paralysis: drooling, eye complications (exposure keratitis, corneal ulcer, panophthalmitis), facial contractures, and psychological disturbance (depression, suicidal tendencies).
Complications from abnormal degeneration: facial tics/spasms (short-circuiting between nerve fibers), Synkinesis (abnormal mass movement, e.g., eye closes when smiling), Crocodile tears (misdirected salivary fibers to lacrimal gland, causing crying while eating), and Frey's syndrome (facial flushing/sweating over the parotid during mastication from misdirected salivary fibers to sweat glands).

Describe the treatment approach for facial nerve paralysis, including facial re-animation surgery options.

Treatment includes treating the underlying cause, treating complications (e.g., gold weight for corneal protection, facial plastic surgery for contractures), and facial re-animation surgery.
Re-animation includes restoring anatomical nerve integrity (facial nerve decompression, anastomosis, and grafting, indicated in Bell's palsy, Herpes zoster oticus, otitis media, trauma, and tumors) and restoring functional neuromuscular integrity via nerve substitution (e.g., facial-hypoglossal anastomosis) or muscle substitution techniques (e.g., masseter/temporalis muscle transfer), plus facial rehabilitation (massage, heat, exercises).

Describe Bell's Palsy, including its epidemiology, etiology, and clinical presentation.

Bell's Palsy is a sudden flaccid (LMNL) facial paralysis in an otherwise healthy individual, with an incidence of 1/5000 per year, making it the most common form of facial paralysis, attributed to sudden cold exposure.

It is caused by reactivation of Herpes Simplex Virus, which causes edema that compresses the nerve within the narrow bony canal; it remains a diagnosis of exclusion.

Clinically, it presents with sudden LMN-type paralysis, ear pain in over half of patients, maximum severity within 3 days, and recovery usually starting within 3 weeks even without treatment.

Describe the prognosis and treatment (conservative and surgical) of Bell's Palsy.

Conservative treatment helps in 96% of cases: Zovirax (800mg 5x daily for one week), steroids like Prednisolone (with caution for diabetes/hypertension), and crucially eye care (artificial tears, ointments, dark glasses to prevent exposure keratitis).

Surgical treatment (facial nerve decompression via middle cranial fossa) is reserved for complete paralysis with more than 90% degeneration on ENoG within 6 days; if no recovery occurs after several months, reconsider the diagnosis for a possible tumor.

Describe Herpes Zoster Oticus (Ramsay Hunt Syndrome), including its triad, prognosis, and treatment.

Ramsay Hunt Syndrome represents 5-15% of acute facial palsy cases, with palsy appearing 2-7 days after a burning ear sensation (the first alarm sign), caused by diffuse lymphocytic infiltration; vesicles may also affect the palate and anterior two-thirds of the tongue.

Its triad is: facial paralysis, auditory/vestibular dysfunction, and painful herpetic vesicles of the auricle and EAC.

Prognosis is worse than Bell's palsy (nerve more severely damaged): only 30% recover normal function, 30-50% show incomplete recovery, and 70% experience some sequelae. Treatment includes early Acyclovir (800mg 5x daily for a week), oral steroids (1mg/kg/day for 2 weeks), and decompression if degeneration exceeds 90% in 2 weeks.

Describe the accidental and iatrogenic causes of facial nerve trauma, including a key pediatric anatomical consideration.

Accidental trauma includes petrous temporal bone fractures (facial nerve injury in 10% of longitudinal fractures versus 40% of transverse fractures, commonly at the geniculate ganglion) and rare extratemporal direct trauma.

Iatrogenic causes include unintentional injury during postauricular abscess incision in infants, classical/radical mastoidectomy, congenital ear surgery, and CPA surgery; Intraoperative Facial Nerve Monitoring (IOM) helps prevent this.

In infants, the mastoid bone is undeveloped until after age 2, leaving the nerve very shallow, so postauricular abscess incisions must be made oblique and above the tragus level.

Define the Middle Ear Cleft and Mucoperiostitis, and differentiate Acute Otitis Media from Chronic Suppurative Otitis Media (CSOM).

The Middle Ear Cleft is a mucosa-lined cavity in the petrous temporal bone comprising the tympanic cavity, Eustachian tube, mastoid antrum, and mastoid air cells.
Mucoperiostitis refers to inflammation of this mucosa, which is tightly adherent to the underlying periosteum.
Acute Otitis Media (AOM) has sudden onset, a short course, and can heal completely without residue, while CSOM has insidious onset, a protracted course, and causes irreversible tissue pathology (permanent drum perforation, ossicular necrosis, fibrosis).

Differentiate the Tubotympanic (Safe) and Atticoantral (Unsafe) types of CSOM, including their naming rationale.

Tubotympanic Type is the "Safe type," associated with zero life-threatening complications, named because infection travels via the Eustachian tube to the tympanic cavity.

Atticoantral Type is the "Unsafe type," highly dangerous and always eventually leading to fatal complications (whether within 1 or 20 years), named because the unsafe pathology (cholesteatoma) is located in the attic and antrum.

Describe the clinical features of Tubotympanic (Safe) CSOM, including otorrhea characteristics and otoscopic findings.

Otorrhea is mucopurulent, odorless (same microbe as common cold, no bone necrosis), profuse (from the large mucosal surface area), and intermittent (coinciding with URTIs or water exposure).
Hearing loss is mild-to-moderate conductive type.

Otoscopy shows a central perforation strictly within the pars tensa (never the pars flaccida), with granulation tissue and cholesteatoma entirely absent; X-ray shows a "cellular" mastoid (sponge-like black air cells separated by white septa).

Describe the treatment strategy for Tubotympanic CSOM, including factors preventing spontaneous closure and surgical options.

Treatment has two steps: medical phase (convert wet ear to dry ear with antibiotics before surgery) and surgical phase (close the perforation).

Spontaneous closure is prevented by perforation size (subtotal are hardest), poor systemic health (diabetes, poor nutrition), and migrating squamous skin lining the margin, which cannot cross to the drum's undersurface in central perforations (forming a permanent non-healing hole) but destroys middle ear structures in marginal perforations.

Medical management uses chemical cautery (trichloroacetic acid, silver nitrate); surgical options include Myringoplasty (95% success), Ossiculoplasty, and Tympanoplasty (combined), via post-auricular (temporalis fascia graft) or endomeatal (tragal perichondrium graft) approaches.

Define Cholesteatoma and describe its formation mechanism, including congenital versus primary acquired types.

Cholesteatoma is a destructive, expanding keratinizing squamous epithelium trapped within the middle ear or mastoid; skin entering this closed cavity divides without friction stimulus, forming an expanding sac that causes ischemic bone necrosis, exposing vital structures (brain, cerebellum, meninges) if untreated.

Congenital Cholesteatoma arises from an ectodermal cell rest in the middle ear mesoderm during embryogenesis, appearing as a white pearl behind an intact eardrum.

Primary Acquired (Atticoantral) Cholesteatoma results from chronic negative middle ear pressure (from Eustachian tube dysfunction/adenoids), causing the weak pars flaccida to retract into an invaginated sac forming the cholesteatoma in the attic.

Treatment is always surgical (mastoidectomy), as antibiotics cannot cure a bone-eating skin sac.

Create a comparison of Safe versus Unsafe CSOM across discharge, organism, deafness, pain, and radiological findings.

Safe Type: mucopurulent/odorless/profuse/intermittent discharge; Gram-positive organisms (Staph, Strept); mild-moderate conductive deafness; painless; lacks bleeding; central pars tensa perforation; cellular mastoid X-ray (sponge-like).

Unsafe Type: purulent/foul-smelling/scanty/continuous discharge; Gram-negative organisms (Pseudomonas, E. coli); moderate-severe conductive or sensorineural/mixed loss (can erode inner ear); dull aching pain from bone destruction; bleeds easily (granulations/polyps); marginal perforation or pars flaccida perforation with visible cholesteatoma flakes; acellular/sclerotic (white) mastoid X-ray with radiolucent filling defect.

Describe the anatomical pathways and classification of CSOM complications, plus the presentation of Mastoiditis and Petrositis (Gradenigo's Syndrome).

Infection spreads via bone erosion (most common, from cholesteatoma) or preformed pathways (dehiscences, fracture lines);
by wall: lateral wall leads to perforation, medial wall to labyrinthitis/facial paralysis, superior wall (tegmen tympani) to meningitis/brain abscess, posterior wall (mastoid) to mastoiditis (most common complication), inferior wall to vascular complications.

Complications are classified as Cranial/Intratemporal (mastoiditis, petrositis, labyrinthitis, facial paralysis),
Intracranial (meningitis, abscesses, lateral sinus thrombosis), and
Extracranial (external otitis, neck abscesses).

Mastoiditis presents with fever, earache, and profuse discharge, progressing to coalescent mastoiditis, subperiosteal abscess, or canal sign (sagging meatal wall); treated with IV antibiotics or cortical mastoidectomy if it fails.
Petrositis presents as Gradenigo's Syndrome: otorrhea, retro-orbital pain (CN V involvement), and diplopia (CN VI palsy causing lateral rectus paralysis)